Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

esteve pharmaceuticals ltd - mupirocin - cutaneous ointment - 20mg/1gram

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

orthoneutrogena, division of ortho-mcneil pharmaceutical, inc. - mupirocin (unii: d0gx863oa5) (mupirocin - unii:d0gx863oa5) - ointment - centany (mupirocin ointment),2% is indicated for the topical treatment of impetigo due to: staphylococcus aureus and streptococcus pyogenes . this drug is contraindicated in individuals with a history of sensitivity reactions to any of its components.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - mupirocin, quantity: 22 mg/g - ointment - excipient ingredients: macrogol 3350; macrogol 400 - bacrtoban (mupirocin) ointment is indicated for the topical treatment of mild impetigo.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - mupirocin (unii: d0gx863oa5) (mupirocin - unii:d0gx863oa5) - mupirocin ointment is indicated for the topical treatment of impetigo due to susceptible isolates of staphylococcus aureus (s. aureus) and streptococcus pyogenes (s. pyogenes). mupirocin ointment is contraindicated in patients with known hypersensitivity to mupirocin or any of the excipients of mupirocin ointment. teratogenic effects pregnancy category b. there are no adequate and well-controlled studies of mupirocin ointment in pregnant women. because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. developmental toxicity studies have been performed with mupirocin administered subcutaneously to rats and rabbits at doses up to 160 mg per kg per day in both species. this dose is 22 and 43 times, respectively, the human topical dose (approximately 60 mg mupirocin per day) based on body surface area. there was no evidence of fetal harm due to mupirocin. it is not known whether this drug is excreted in human milk. because m

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - mupirocin (unii: d0gx863oa5) (mupirocin - unii:d0gx863oa5) - mupirocin ointment usp, 2% is indicated for the topical treatment of impetigo due to susceptible isolates of staphylococcus aureus (s. aureus) and streptococcus pyogenes (s. pyogenes) . mupirocin ointment is contraindicated in patients with known hypersensitivity to mupirocin or any of the excipients of mupirocin ointment. pregnancy category b. there are no adequate and well-controlled studies of mupirocin ointment in pregnant women. because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. developmental toxicity studies have been performed with mupirocin administered subcutaneously to rats and rabbits at doses up to 160 mg per kg per day in both species. this dose is 22 and 43 times, respectively, the human topical dose (approximately 60 mg mupirocin per day) based on body surface area. there was no evidence of fetal harm due to mupirocin. it is not known whether this drug is excreted in human milk. because many drugs a

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - mupirocin - cutaneous ointment - 20mg/1gram

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - mupirocin - cutaneous ointment - 20mg/1gram

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - mupirocin - cutaneous ointment - 20mg/1gram

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - mupirocin - cutaneous ointment - 20mg/1gram

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

medsurge pharma limited - mupirocin calcium 21.5 mg/g equivalent to mupirocin 20mg/g - topical ointment - 2% w/w - active: mupirocin calcium 21.5 mg/g equivalent to mupirocin 20mg/g excipient: bis-diglyceryl polyacyladipate-2 white soft paraffin - mupirocin nasal ointment is indicated for the elimination of nasal carriage of staphylococci, including methicillin resistant staphylococcus aureus (mrsa).